The cutaneous autoimmunity group is led by Dr Thomas Tull.

Our research focusses on pathogenic B cell responses in immunobullous and connective tissue diseases. We seek  to advance our understanding of the pathogenesis of these diseases and to identify potential novel therapeutic targets. Our work also seeks to understand how the skin acts as a lymphoid organ, both in normal homeostasis and in autoimmune conditions.